क्यूआर कोड

Sex Differences in Treatment Expectations, Satisfaction and Tolerance After Switching to CT-P17, an Adalimumab Biosimilar: A Post Hoc Analysis of the YU-MATTER Study

Abstract Introduction Data suggest that women and men differ in how they experience biological treatment. This post hoc analysis of the YU-MATTER study evaluated sex-related differences in patient satisfaction and perception when switching from adalimumab (reference or biosimilar) to CT-P17 (Yuflyma...

पूर्ण विवरण

में बचाया:
मुख्य लेखकों: Laure Gossec, Guillaume Bouguen, Azeddine Dellal, Lucile Foulley, Caroline Habauzit, Salim Benkhalifa, Hubert Marotte
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Adis, Springer Healthcare 2026-03-01
श्रृंखला:Rheumatology and Therapy
विषय:
Adalimumab
Adverse events
Biosimilar
CT-P17
Injection site reactions
Patient-reported outcomes
ऑनलाइन पहुंच:https://doi.org/10.1007/s40744-026-00840-7
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन